Clinical Trial Update: Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer

View source ↗

Summary

A completed study assessing real-world administration of chemotherapy combined with bevacizumab in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED